Evalon
Active substance
ATC code
Species
Chickens.
Indications
For active immunisation of chicks from 1 day of age to reduce clinical signs (diarrhoea), intestinal lesions and oocysts output associated with coccidiosis caused by Eimeria acervulina, Eimeria brunetti, Eimeria maxima, Eimeria necatrix and Eimeria tenella.
Onset of immunity: 3 weeks post-vaccination.
Duration of immunity: 60 weeks post-vaccination in an environment that permits oocysts recycling.
Dose to be administered and administration route
Oral use.
The method of administration is by coarse spray.
Vaccination schedule:
One dose of vaccine (0.007 ml) from 1 day of age.
Administration route:
The method of administration is by coarse spray by using a suitable device (volume delivered: 28 ml / 100 chicks, droplet size: 200 – 250 µm and working pressure: 2 to 3 bars). Before starting the preparation, make certain to have a clean container available with sufficient capacity for preparing the diluted vaccine suspension. Dilute the vaccine with the corresponding volumes:
Doses | Water | Vaccine | Solvent | Total |
1 000 | 223 ml | 7 ml | 50 ml | 280 ml |
5 000 | 1 115 ml | 35 ml | 250 ml | 1 400 ml |
10 000 | 2 230 ml | 70 ml | 500 ml | 2 800 ml |
Shake the solvent vial. Dilute the content of the vial with clean room temperature water into an appropriate container.
Shake the vaccine vial and dilute the content into the previous solution.
Fill the reservoir of the spraying device with all the vaccine suspension prepared.
Maintain the diluted vaccine suspension in continuous homogenisation by using a magnetic stirrer while the vaccine is being administered via coarse spray to the chicks.
To improve the uniformity of thevaccination maintain the chicks inside the transportation box for at least 1 hour in order to let them ingest all the vaccine droplets.
After this time, place the chicks carefully in the litter and continue with regular management practices.
The device should be cleaned after each use. See the manufacturer’s instructions to ensure proper disinfection and maintenance of the device.
Adverse reactions
Chickens:
None.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
